第 1 到 9 筆結果,共 9 筆。
公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2020 | EpCAM signaling promotes tumor progression and protein stability of PD-L1 through EGFR pathway | Chen, H. N.; Liang, K. H.; Lai, J. K.; Lan, C. H.; Liao, M. Y.; Hung, S. H.; Chuang, Y. T.; Chen, K. C.; Tsuei, W. W. F.; Wu, H. C. | Cancer Research 80(22), 5035-5050 | |||
2 | 2020 | Potent neutralizing antibody cocktail for prevention and treatment of COVID-19. | Wu, H. C. | ||||
3 | 2020 | Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer | Ke, F. Y.; Chen, W. Y.; Lin, M. C.; Hwang, Y. C.; Kuo, K. T.; Wu, H. C. | Cancer Science 111(10), 3478-3492 | |||
4 | 2020 | Novel SARS-CoV-2-Neutralizing antibodies for prevention and treatment of COVID-19 | Wu, H. C. | ||||
5 | 2020 | Imaging and biodistribution of radiolabeled SP90 peptide in BT-483 tumor bearing mice | Lo, WL; Liang, CH; Chen, LC; Lee, SY; Lo, SN; Chen, MW; Lu, RM ; Liu, IJ; Wu, HC ; Chang, CH | Applied Radiation and Isotopes 161, 109162 | |||
6 | 2020 | Novel anti-EGFR scFv human antibody-conjugated immunoliposomes enhance chemotherapeutic efficacy in squamous cell carcinoma of head and neck | Wang, Y. P.; Liu, I. J.; Chung, M. J.; Wu, H. C. | Oral Oncology 106, 104689 | |||
7 | 2020 | Development of therapeutic antibodies for the treatment of diseases | Ruei-Min Lu ; Yu-Chyi Hwang; I-Ju Liu; Chi-Chiu Lee; Han-Zen Tsai; Hsin-Jung Li; Han-Chung Wu | Journal of Biomedical Science 27, 1 | |||
8 | 2020 | Peptide Targeting Methods | Lu, Ruei-Min ; Wu, Chien-Hsun; Patil Ajay V.; Wu, Han-Chung | Handbook of In Vivo Chemistry in Mice: From Lab to Living System (USA : Wiley-VCH) | |||
9 | 2020 | CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway | Cheng, Chih-Lun; Yang, Shang-Chih; Lai, Chien-Ying; Wang, Cheng-Kai; Chang, Ching-Fang; Lin, Chun-Yu; Chen, Wei-Ju; Lin, Po-Yu; Wu, Han-Chung ; Ma, Nianhan; Lu, Frank Leigh; Lu, Jean | Cells 9(7), 1706 |